Optimization and evaluation of transdermal delivery system for nebivolol hydrochloride

• Asıl Yazarlar: P V Shelke (Yazar), Punit R Rachh (Yazar), S D Mankar (Yazar), Prasad L. Gorde (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Creative Pharma Assent, 2024-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Nebivolol hydrochloride, a β1-receptor antagonist known for its antihypertensive properties, boasts a plasma half-life of 10 hours and an oral bioavailability of 12%. In this study, we aimed to enhance the therapeutic effectiveness of Nebivolol hydrochloride and circumvent its extensive...